Skip to main content

Month: April 2021

iFresh Partners with E-commerce Platform Yami to Extend Online Marketplace Business

NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — iFresh, Inc. (“iFresh” or the “Company”) (Nasdaq: IFMK), a leading Asian American grocery supermarket chain and online grocer, today announced that it is partnering with Yami (formerly Yamibuy), an e-commerce platform based in Los Angeles, CA. This partnership extends iFresh’s fresh grocery, food products, and snack sales to Yami extensive nationwide network beyond iFresh’s current market through Yami’s direct-to-customer platform. The Company expects that the partnership will provide Yami’s customers with the opportunity to purchase iFresh products. The two parties have laid out necessary groundwork and preparation since November 2020, and diligently prepared for the launch this year. Starting on March 9th, 2021, Yami has made iFresh’s varied selection of groceries, snacks, and other...

Continue reading

Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report first quarter 2021 financial results on Thursday, May 6, 2021, after the close of the market. Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host a conference call and webcast at 2:00 p.m. PT, 5:00 p.m. ET, on May 6, 2021, to discuss first quarter 2021 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call. Individuals interested in listening to the conference call may do so by dialing: US domestic callers: (877) 556-5248Outside US callers: (720) 545-0029Please reference...

Continue reading

Industrial Sorting Tests increase by 170 % the Grade of the Mineralisation of the Chimo Mine Property

Highlights :The industrial sorting tests of mineralisation representative of the Chimo Mine project produced a concentrate representing by mass a bit more than 50 % of the original mass of the material with a percentage increase of 170 % of the gold content compared to the feed of the sorter; The sorting tests carried out by Corem and by Steinert US are comparable and these result in positive conclusions which bode well for increasing the value of the resources with the mineralization sorting technology. The objective of the industrial sorting of the mineralization is to increase the grade of the preconcentrated material preceding the milling operations, which allows to:Increase the recovery rate at the mill; Reduce transport costs to the mill; Reduce milling costs; Reduce the costs of environmental restoration of mine tailings; Reduce...

Continue reading

Les essais de tri industriel augmentent de 170 % la teneur de la minéralisation de la propriété Mine Chimo

Faits saillants :Les essais de tri industriel de la minéralisation représentative de Mine Chimo ont permis de produire un concentré représentant un peu plus de 50 % de la masse du matériel original avec un pourcentage d’augmentation de 170 % de la teneur en or par rapport à l’alimentation de la trieuse ; Les essais de tri réalisés par Corem et par Steinert US sont comparables et ceux-ci résultent sur des conclusions positives qui augurent bien pour accroître la valeur des ressources avec la technologie de triage de la minéralisation. Le tri industriel de la minéralisation a pour objectif d’accroître la teneur du matériel préconcentré précédant les opérations d’usinage, ce qui permet :D’accroître le taux de récupération à l’usine ; De réduire les coûts de transport vers l’usine ; De réduire les coûts d’usinage ; De réduire les coûts...

Continue reading

Elizabethtown Gas Receives Approval of Its Largest Ever Energy-Efficiency Program and a Conservation Incentive Program

UNION, NJ, April 08, 2021 (GLOBE NEWSWIRE) —  Media Contact: Dominick DiRocco (609) 561-9000 ext. 4262 ddirocco@sjindustries.com                                                                                                           Investor Contact: Dan Fidell(609) 561-9000 ext. 7027dfidell@sjindustries.com FOR IMMEDIATE RELEASE                              Elizabethtown Gas Receives Approval of Its Largest Ever Energy-Efficiency Program and a Conservation Incentive Program  Aligning Clean Energy Investments with State Environmental Goals, Helping Customers Save Money and Generating Jobs In New Jersey UNION, NJ, April 8, 2021 –  Elizabethtown Gas (ETG), a subsidiary of SJI (NYSE:SJI) announced today that it received New Jersey Board of Public Utilities (NJBPU) approval to significantly expand its energy-efficiency program,...

Continue reading

Atlantica Announces an Agreement to Acquire a 49% Interest in a 596 MW Wind Portfolio in the US

April 8, 2021 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica”), the sustainable infrastructure company that owns a diversified portfolio of contracted assets in the energy and environment sectors, announced today that it has reached an agreement to acquire a 49% interest in a 596 MW portfolio of four wind assets located in Illinois, Texas, Oregon and Minnesota. Atlantica’s initial investment is expected to be approximately $196.51 million. The  transaction price represents an Enterprise Value2 / EBITDA3 multiple of approximately 5.9 times. The portfolio has no debt as of today and Atlantica expects to potentially raise non-recourse debt in the future in order to reduce the investment. The assets have PPAs with investment grade off-takers with 5 years average remaining contract life and have demonstrated proven operational...

Continue reading

Galane Gold Announces Execution of Definitive Agreement for the Acquisition of the Summit Mine in New Mexico and Closing of C$9.68 Million Private Placement With Lead Order From Palisades Goldcorp

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — Galane Gold Ltd. (“Galane Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce that it has entered into a definitive agreement to acquire (the “Acquisition”), through a wholly-owned subsidiary, the Summit Mine (the “Mine”) and the infrastructure constituting the Banner Mill in New Mexico (collectively, the “Assets”) from Pyramid Peak Mining, LLC, a wholly-owned subsidiary of Waterton Precious Metals Fund II Cayman, LP.   Closing of the Acquisition is expected to occur on or about May 16, 2021, and is subject to certain conditions including, but not limited to, completion of a confirmatory title report on the Assets and approval of governmental and regulatory authorities, including the TSX Venture Exchange (“TSXV”). For further details on the Acquisition and...

Continue reading

Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy

APX3330 has the Potential to be a Novel Oral Treatment Option with Dual Mechanism of Anti-VEGF and Anti-Inflammatory for Diabetic Retinopathy Top Line Data from ZETA-1 Expected by Early 2022 FARMINGTON HILLS, Mich., April 08, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced today that it has screened the first patient in ZETA-1, a Phase 2 trial to evaluate APX3330 in non-proliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (mild PDR). Effects on diabetic macular edema will be explored as a secondary outcome. A number of retinal centers across the US are active and recruiting eligible diabetic retinopathy patients. Diabetes is...

Continue reading

Claritas to Expand R-107 Program to Include Treatment of Sepsis, the Leading Cause of Death in COVID-19 Patients

SAN FRANCISCO and TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas“) today announced that, based on significantly positive results in a controlled large animal model of sepsis, the Company will now expand its R-107 development program to include the treatment of COVID-19 related sepsis, the leading cause of death in COVID-19 patients.   Highlights Claritas is currently developing R-107 for the treatment of viral infections, including vaccine-resistant COVID-19.  Claritas will also now expand this program to include development of R-107 for the treatment of COVID-19 related sepsis.  Sepsis is the leading cause of death in COVID-19 patients, with a mortality rate of 30% – 40%.1Positive Results with R-107 in Treatment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.